Intravital microscopy was performed in vivo on calvaria and ex vivo on femurs with a confocal microscope (IV100 Olympus) as outlined in Online Figure I. A field of view at 4X magnification covered a 2290μm*2290μm, and 20X a 458μm*458μm dataset of 512 × 512 pixels. Z-stack images were acquired at 2μm steps. For in vivo imaging, mice were shaved at the skull and held in a stereotaxic skull holder. A skin incision revealed the calvaria, and glycerin (Sigma-Aldrich) was applied to prevent the tissue drying. The calvarian bone marrow was exposed as described before7. To delineate bone marrow cavities in the calvaria, OsteoSense® 750EX, a fluorescent bisphosphonate imaging agent, was administered intravenously 24 hours prior to imaging (4 nmol/mouse, NEV10053EX, PerkinElmer). IntegriSense™ 680, as an angiogenic marker for integrin αvβ3 activation, was administered intravenously 24 hours prior to imaging (2 nmol/mouse, NEV10645, PerkinElmer).
To outline the vasculature, we used FITC anti-CD31 (50μl, MEC13.3, 102514, Biolegend). To assess VEGFR2 activation, APC anti-VEGFR2 (Avas 12, 136406, Biolegend) was used in combination with IntegriSense 750™ (2 nmol/mouse, PerkinElmer, NEV10873). To analyze vascular leak, we followed a single plane through the center of the marrow cavities over 6min at a frame rate of 0.2083 frames/sec before and after bolus injection through an indwelling tail vein catheter of bovine serum albumin (BSA) labeled with rhodamine B and gadopentetic acid (GdDTPA) (RhoB-albumin-GdDTPA; excitation/emission: 555nm / 581nm, 82kDa, 2.5mg/mouse, Symochem, The Netherlands). For serial permeability imaging, FITC-albumin (495nm; 66kDa; 2.5mg/mouse; Sigma) was employed with the same temporal settings. To follow the cells serially by intravital microscopy of the calvarium, LSK (Lin-Sca-1+c-Kit+) were labeled ex vivo with the Vybrant® DiD Cell-Labeling Solution (1,1′-dioctadecyl-3,3,3′,3′- tetramethylindodicarbocyanine perchlorate, Molecular Probes®) according to manufacturer’s protocol. C57BL/6 mice were then intravenously injected with 75,000 labeled LSKs. In vivo imaging was performed using a confocal microscope (IV100 Olympus) on days 1 (day 0) and 2 (day 1) after adoptive cell transfer. Separately, 30min after intravenous injection of APC anti-Ly6G (1A8; Biolegend), Ly6G+ neutrophils were imaged on day 0 and day 1. For LSK and Ly6+ neutrophil serial imaging, LPS was injected intraperitoneally directly after the imaging session at day 0. After intravital microscopy, animals were sacrificed and femurs were dissected in 4% PFA and embedded in OCT. Femurs were shaved 300μm with a cryostat at −25°C to expose the bone marrow. These long bones were then thawed and imaged by confocal microscopy (IV100 Olympus) or by an epifluorescence imaging system (OV110 Olympus).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.